- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Mar 13, 2026 | 69.06M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 73.31M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 73.31M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 75.12M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 120.23M sh |
| Cash And Equivalents | Q2 2026 · Jan 31, 2026 | $28.31K |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $18.05K |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | −$968.03K |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | −$728.08K |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $725.78K |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $877.66K |
| Total Liabilities | Q2 2026 · Jan 31, 2026 | $1.15M |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $963.61K |
| Current Assets | Q2 2026 · Jan 31, 2026 | $28.31K |
| Current Assets | Q2 2026 · Jul 31, 2025 | $19.3K |
| Total Assets | Q2 2026 · Jan 31, 2026 | $182.39K |
| Total Assets | Q2 2026 · Jul 31, 2025 | $235.53K |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $0.00 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $0.00 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $0.02 |
| Eps Diluted restated | Q2 2026 · Jan 31, 2025 | $0.02 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $0.00 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $0.00 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $0.02 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $0.02 |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $108.2K |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $242.23K |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $176.93K |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $363.49K |
| Net Income | Q2 2026 · Jan 31, 2026 | −$152.88K |
| Net Income | Q2 2026 · Jan 31, 2026 | −$301.76K |
| Net Income | Q2 2026 · Jan 31, 2025 | $1.38M |
| Net Income | Q2 2026 · Jan 31, 2025 | $940K |
| Operating Income | Q2 2026 · Jan 31, 2026 | −$139.27K |
| Operating Income | Q2 2026 · Jan 31, 2026 | −$304.38K |
| Operating Income | Q2 2026 · Jan 31, 2025 | −$347.58K |
| Operating Income | Q2 2026 · Jan 31, 2025 | −$703.16K |
| Revenue | Q2 2026 · Jan 31, 2026 | $0 |
| Revenue | Q2 2026 · Jan 31, 2026 | $0 |
| Revenue | Q2 2026 · Jan 31, 2025 | $0 |
| Revenue | Q2 2026 · Jan 31, 2025 | $0 |